Moffitt Cancer Center, Magnolia Campus

Tampa, Florida 33612

3 studies enrolling now · 5 studies all time

What they study most

Advanced Non-small Cell Lung Cancer, HER2 Mutation, Cutaneous Melanoma, Stage II, Head and Neck Squamous Cell Carcinoma, Lymphoma, T-Cell, Non Small Cell Lung Cancer

Studies at this site

• A Study to Learn More About How Well Sevabertinib Works and How Safe it is Compared With Standard Treatment, in Participants Who Have Advanced Non-small Cell Lung Cancer (NSCLC) With Mutations of the Human Epidermal Growth Factor Receptor 2 (HER2) — Recruiting now
• MB-105 in Patients With CD5 Positive T-cell Lymphoma — Recruiting now
• Melanoma Margins Trial-II: 1cm v 2cm Wide Surgical Excision Margins for AJCC Stage II Primary Cutaneous Melanoma — Recruiting now
• Quaratusugene Ozeplasmid (Reqorsa) in Combination With Pembrolizumab in Previously Treated Non-Small Lung Cancer — Stopped early
• FID-007 and Cetuximab in Treating Patients With Advanced Head and Neck Squamous Cell Carcinoma — Running, not enrolling